To Assess the Effectiveness and Safety of Zepzelca in Adult Patients With Extensive Stage Small Cell Lung Cancer (SCLC)
Clinical trial NCT04894591 · COMPLETED
Trial details
- NCT number
- NCT04894591
- Sponsor
- Jazz Pharmaceuticals
- Status
- COMPLETED
- Study type
- OBSERVATIONAL
- Start date
- 2021-06-28
- Primary completion
- 2025-06-04
- Enrollment
- 272
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.